RCEL · NASDAQ · Medical - Devices

AVITA Medical (RCEL)

Builds RECELL-based wound-care products for burns, trauma, and skin defects.

$11.53
vs last close+0.68 (+6.32%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue141411152018191817181922
Cost of revenue222232333344
Gross profit121210131616161514141618
212527293026282623252525
Research & development475555654665
171822242521212119191920
Selling & marketing111013161514151412121314
General & administrative6898107677766
Other expenses000000000000
Operating income−9−12−17−16−14−10−12−11−9−10−9−7
15−10−2−2−21−4−1−2−1
Interest income000000000000
Interest expense011111111111
Other non-operating income−1−60−2101−2300−1
Income before tax−9−7−19−15−16−12−14−10−13−12−11−8
Income tax expense000000000000
Net income from continuing operations−9−7−19−15−16−12−14−10−13−12−11−8
Net income−9−7−19−15−16−12−14−10−13−12−11−8
EPS, basic−$0.53−$0.28−$0.73−$0.60−$0.62−$0.44−$0.53−$0.38−$0.46−$0.38−$0.36−$0.25
EPS, diluted−$0.53−$0.28−$0.73−$0.60−$0.62−$0.44−$0.53−$0.38−$0.46−$0.38−$0.36−$0.25
Weighted average shares, basic252526262626262628302931
Weighted average shares, diluted252526262626262628302931
EBITDA−9−6−17−14−15−10−12−8−11−10−9−5
Depreciation & amortization000000111111
EBIT−9−6−17−14−15−10−13−9−12−10−9−6